Showing results (61-70 of 219) with videos related to
Sort By:
Pageof 22
Haematology and Blood Transfusion|January 1, 1990
Pharmacologically directed design of leukemia therapyW Plunkett, V Heinemann, E Estey, et al.Family and Consumer Sciences Research Journal|January 22, 2024
Life Quality of University Students From Immigrant Families in the United StatesFarin Bakhtiari, Aprile D Benner, Scott W PlunkettJournal of Health Psychology|May 5, 2018
Factor structure and validity of the Affective Style QuestionnaireRui Jiang, Scott W Plunkett, Andrew T AinsworthMolecular Pharmacology|March 22, 2001
2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrestA Azuma, P Huang, A Matsuda, et al.Cancer Research|August 15, 1991
Plasma and cerebrospinal fluid pharmacokinetics of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil following the repeated intravenous administration of high- and intermediate-dose 1-beta-D-arabinofuranosylcytosineL E Damon, W Plunkett, C A LinkerBiochemical Pharmacology|May 30, 2001
Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC)A Azuma, P Huang, A Matsuda, et al.Cancer Research|November 1, 1985
Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosineJ O Liliemark, W Plunkett, D O DixonCancer Chemotherapy and Pharmacology|January 1, 1986
9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphomaL Danhauser, W Plunkett, M Keating, et al.Digestive Diseases and Sciences|December 1, 1990
Primary peritoneal sarcoidosisL E Robertson, J T CunninghamTexas Medicine|November 1, 1991
Therapeutic approaches to chronic lymphocytic leukemiaL E Robertson, M J KeatingPageof 22